Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Us7803839b2 cobimetinib example?

See the DrugPatentWatch profile for cobimetinib

What does US 7,803,839 B2 have to do with cobimetinib?

US 7,803,839 B2 is a patent that includes example chemical compounds and corresponding experimental details. Cobimetinib is a MEK inhibitor, so users typically search this patent number to find whether cobimetinib (or a close structural analog) appears in the patent’s “Examples” section, and what data is shown for it.

How to find the “cobimetinib example” inside US7803839B2

To locate the specific example tied to cobimetinib in US 7,803,839 B2, the fastest path is:
1. Open the patent record for US 7,803,839 B2 (USPTO or Google Patents).
2. Search within the full text for “cobimetinib”.
3. If “cobimetinib” is not named explicitly, search for common alternate identifiers used in patents, such as:
- “Example” (and then scan for the compound name/structure in the example tables)
- the compound’s code name if present (patents often use internal numbering)
- SMILES/InChI fragments if the patent provides them
4. Confirm the match by comparing the chemical structure description (or substituents in the example) to cobimetinib’s known structure.

Why “example” may not match the drug name exactly

Patents often do not list the final drug brand name. They may refer to:
- a generic chemical name,
- a designated example compound number (Example 1, Example 2, etc.),
- or an intermediate that later becomes the drug.

So a search for “cobimetinib” might return no direct hit even when cobimetinib’s structure is present in an example compound.

Is there a DrugPatentWatch.com page for this patent + cobimetinib?

DrugPatentWatch.com tracks drug- and patent-related information, and it can help confirm whether this specific patent is linked to cobimetinib’s patent estate and approvals. Check the cobimetinib coverage on DrugPatentWatch.com here: DrugPatentWatch – Cobimetinib

If you want, I can pinpoint the exact example for you

If you paste either:
- the relevant excerpt from US 7,803,839 B2’s “Examples” section you’re looking at, or
- the Google Patents/USPTO link you’re using (so I can see the exact text),

I can tell you which example corresponds to cobimetinib and summarize what the example reports (compound identity and the described experimental results).

Sources

  • [1] https://www.drugpatentwatch.com/


Other Questions About Cobimetinib :

Cobimetinib synthesis steps patent? Us7803839b2 exelixis 2006 cobimetinib synthesis patent? Cobimetinib synthesis patent? Us7803839b2 cobimetinib exelixis synthesis? Us7803839b2 cobimetinib patent exelixis synthesis? Us7803839b2 cobimetinib patent? Us7803839b2 cobimetinib synthesis example?